139 related articles for article (PubMed ID: 26482333)
41. Costs of rearing children in agricultural economies: an alternative estimation approach and findings from rural Bangladesh.
Khan MM; Magnani RJ; Mock NB; Saadat YS
Asia Pac Popul J; 1993 Mar; 8(1):19-38. PubMed ID: 12286245
[TBL] [Abstract][Full Text] [Related]
42. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
Tunis SL; Willis WD; Foos V
Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
[TBL] [Abstract][Full Text] [Related]
43. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study.
Ribeiro RC; Steliarova-Foucher E; Magrath I; Lemerle J; Eden T; Forget C; Mortara I; Tabah-Fisch I; Divino JJ; Miklavec T; Howard SC; Cavalli F
Lancet Oncol; 2008 Aug; 9(8):721-9. PubMed ID: 18672210
[TBL] [Abstract][Full Text] [Related]
44. Patient costs of diabetes mellitus care in public health care facilities in Kenya.
Oyando R; Njoroge M; Nguhiu P; Sigilai A; Kirui F; Mbui J; Bukania Z; Obala A; Munge K; Etyang A; Barasa E
Int J Health Plann Manage; 2020 Jan; 35(1):290-308. PubMed ID: 31621953
[TBL] [Abstract][Full Text] [Related]
45. Does increased adherence to medications change health care financial burdens for adults with diabetes?
Miller GE; Sarpong EM; Hill SC
J Diabetes; 2015 Nov; 7(6):872-80. PubMed ID: 25817601
[TBL] [Abstract][Full Text] [Related]
46. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
von Ferber L; Köster I; Hauner H
Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
[TBL] [Abstract][Full Text] [Related]
47. Self blood glucose monitoring in type 2 diabetes. A financial impact analysis based on UK primary care.
Belsey JD; Pittard JB; Rao S; Urdahl H; Jameson K; Dixon T
Int J Clin Pract; 2009 Mar; 63(3):439-48. PubMed ID: 19222629
[TBL] [Abstract][Full Text] [Related]
48. Does co-morbid depression impact diabetes related costs? Evidence from a cross-sectional survey in a low-income country.
Chereches RM; Litan CM; Zlati AM; Bloom JR
J Ment Health Policy Econ; 2012 Sep; 15(3):127-38. PubMed ID: 23001281
[TBL] [Abstract][Full Text] [Related]
49. Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil.
Laranjeira FO; Silva EN; Pereira MG
PLoS One; 2016; 11(12):e0167039. PubMed ID: 27907034
[TBL] [Abstract][Full Text] [Related]
50. Estimated Lifetime Economic Burden of Type 1 Diabetes.
Sussman M; Benner J; Haller MJ; Rewers M; Griffiths R
Diabetes Technol Ther; 2020 Feb; 22(2):121-130. PubMed ID: 31886730
[No Abstract] [Full Text] [Related]
51. Health care for children and youth in the United States: annual report on patterns of coverage, utilization, quality, and expenditures by income.
Simpson L; Owens PL; Zodet MW; Chevarley FM; Dougherty D; Elixhauser A; McCormick MC
Ambul Pediatr; 2005; 5(1):6-44. PubMed ID: 15656707
[TBL] [Abstract][Full Text] [Related]
52. A Low-Cost Inkjet-Printed Glucose Test Strip System for Resource-Poor Settings.
Gainey Wilson K; Ovington P; Dean D
J Diabetes Sci Technol; 2015 Jun; 9(6):1275-81. PubMed ID: 26071426
[TBL] [Abstract][Full Text] [Related]
53. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
[TBL] [Abstract][Full Text] [Related]
54. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
55. The cost of diabetes in Latin America and the Caribbean.
Barceló A; Aedo C; Rajpathak S; Robles S
Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
[TBL] [Abstract][Full Text] [Related]
56. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
[TBL] [Abstract][Full Text] [Related]
57. Resource utilization and cost of rheumatic fever.
Terreri MT; Ferraz MB; Goldenberg J; Len C; Hilário MO
J Rheumatol; 2001 Jun; 28(6):1394-7. PubMed ID: 11409136
[TBL] [Abstract][Full Text] [Related]
58. Trends in Blood Glucose Test Strip Utilization: A Population-Wide Analysis in Saskatchewan, Canada.
Kosar L; Alsabbagh W; Lu X; Lix LM; Shevchuk Y; Teare GF; Champagne A; Blackburn DF
Can J Diabetes; 2018 Feb; 42(1):5-10. PubMed ID: 28499790
[TBL] [Abstract][Full Text] [Related]
59. Estimating the global costs of vitamin A capsule supplementation: a review of the literature.
Neidecker-Gonzales O; Nestel P; Bouis H
Food Nutr Bull; 2007 Sep; 28(3):307-16. PubMed ID: 17974364
[TBL] [Abstract][Full Text] [Related]
60. Costs of managing severe hypoglycaemia in three European countries.
Hammer M; Lammert M; Mejías SM; Kern W; Frier BM
J Med Econ; 2009; 12(4):281-90. PubMed ID: 20001570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
